Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Brugada syndrome
ADR ID BADD_A05640
ADR Hierarchy
02      Cardiac disorders
02.03      Cardiac arrhythmias
02.03.01      Cardiac conduction disorders
02.03.01.013      Brugada syndrome
Description An autosomal dominant defect of cardiac conduction that is characterized by an abnormal ST-segment in leads V1-V3 on the ELECTROCARDIOGRAM resembling a right BUNDLE-BRANCH BLOCK; high risk of VENTRICULAR TACHYCARDIA; or VENTRICULAR FIBRILLATION; SYNCOPAL EPISODE; and possible sudden death. This syndrome is linked to mutations of gene encoding the cardiac SODIUM CHANNEL alpha subunit. [MeSH]
MedDRA Code 10059027
MeSH ID D053840
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Brugada syndrome | Brugada Syndrome | Sudden Unexplained Death Syndrome | Brugada Syndrome 1 | Brugada Syndrome 1s | Sudden Unexplained Nocturnal Death Syndrome | Right Bundle Branch Block, ST Segment Elevation, and Sudden Death Syndrome | Sudden Unexplained Nocturnal Death Syndrome (SUNDS) | Brugada ECG Pattern | ECG Pattern, Brugada | Brugada Type ECG Pattern
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00115Amiodarone0.001191%
BADD_D00277Bisoprolol0.001342%
BADD_D00312Bupropion0.000088%
BADD_D00475Citalopram0.000375%
BADD_D00511Clozapine0.028024%
BADD_D00809Escitalopram0.000050%
BADD_D01149Indapamide0.001727%
BADD_D01243Lamotrigine0.000902%
BADD_D01302Lithium--
BADD_D01303Lithium carbonate0.000818%
BADD_D01304Lithium cation--
BADD_D01442Metoclopramide0.000725%
BADD_D01445Metoprolol0.000062%
BADD_D01476Mirtazapine0.000547%
BADD_D01588Nortriptyline0.001337%
BADD_D01856Propafenone0.005747%
BADD_D01867Propranolol0.000380%
BADD_D02329Valproic acid0.000664%
BADD_D02348Verapamil0.000431%
BADD_D02428Loperamide0.003709%
The 1th Page    1    Total 1 Pages